Skip to main content

FDA Disapproves 6,500 Flavored E-cigarettes From Marketing

FDA Disapproves 6,500 Flavored E-cigarettes From Marketing

FDA Disapproves 6,500 Flavored E-cigarettes From Marketing

Introduction

Ten companies that combined produce and market roughly 6,500 flavored e-liquid and e-cigarette products were given marketing denial orders by the U.S. Food and Drug Administration (FDA).

According to the health authority, these businesses cannot promote or distribute the items in the United States, and merchants that do so run the danger of facing FDA enforcement action. FDA must provide a formal marketing order before any firm may legitimately promote a new tobacco product in the United States. However, a marketing denial order is issued if the health regulator decides it is unsafe for the general public's health.

Imperial Vapors LLC, Savage Enterprises, and Big Time Vapes are just a few of the firms the FDA cited as having gotten rejection orders. The FDA stated that it will not reveal the identities of the other two businesses, however, in order to preserve any potentially sensitive commercial information.

According to the FDA, the premarket tobacco product applications (PMTAs) filed for a range of flavor-infused e-cigarette products did not offer enough proof to support the claim that allowing their sale would be in the public's best interest.

The health regulator has prohibited tastes, including citrus, strawberry cheesecake, cool mint, and menthol. Six e-cigarette brands from Altria Group Inc.'s (MO.N) NJOY, on the other hand, have acquired full FDA clearance. 

Altria was formerly an investor in Juul, another manufacturer of e-cigarettes, but Juul is still working to have their goods approved. The FDA momentarily prohibited Juul's products last year but later put the decision on hold and agreed to review after the firm filed an appeal.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!